Johnson Matthey PLC - SWOT Analysis
| Publication Date | February 2008 |
|---|---|
| Publisher | Datamonitor |
| Product Type | Report |
| Pages | 26 |
| ISBN Number | not applicable |
| Product Code | DAT10234 |
Summary
Datamonitor's Johnson Matthey PLC Company Profile is the essential source for top-level company data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Johnson Matthey (JM) is a specialty chemicals group focusing on catalysts, precious metals and fine chemicals. The group is engaged in the manufacture of auto catalysts and pollution control systems, catalysts and components for fuel cells, pharmaceutical compounds, process catalysts and fine chemicals; the refining, fabrication and marketing of precious metals; and the manufacture of colors and coatings for the glass and ceramics industries. The group operates in Europe, North America and Asia. It is headquartered in London, the UK and employs about 7,800 people. The group recorded revenues of 6,151.7 million in the fiscal year ended March 2007, an increase of 34.5% over 2006. The operating profit of the group was 252.4 million in fiscal year 2007, an increase of 25.3% over 2006. The net profit was 206.5 million in fiscal year 2007, an increase of 35.8% over 2006.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to Purchase
- Support sales activities by understanding your customers' businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors' business structure, strategy and prospects
- Obtain the most up to date company information available
Content
- Key Facts
- Company Overview
- Business Description
- Company History
- Key Employees
- Key Employee Biographies
- Company View
- SWOT analysis
- Products & Services Listing
- Products & Services Analysis
About this Product
Delivery Details
PDF:Delivered by email usually within 4 to 8 UK business hours.
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















